Prevalence and antimicrobial susceptibility profile of Corynebacterium glucuronolyticum in genitourinary tract samples

IF 2.6 4区医学 Q3 INFECTIOUS DISEASES

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-03-01 DOI:10.1016/j.eimc.2024.10.007

Ana Cotos Suárez, Fernando García-Garrote, Laura Sancha Domínguez, Ana María Blázquez de Castro, María del Mar Collado Llano, Eva María Lorenzo Iglesias

{"title":"Prevalence and antimicrobial susceptibility profile of Corynebacterium glucuronolyticum in genitourinary tract samples","authors":"Ana Cotos Suárez, Fernando García-Garrote, Laura Sancha Domínguez, Ana María Blázquez de Castro, María del Mar Collado Llano, Eva María Lorenzo Iglesias","doi":"10.1016/j.eimc.2024.10.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div><em>Corynebacterium glucuronolyticum</em> (<em>C. glucuronolyticum</em>) is a species recently recognized as a potential pathogen of the male genitourinary tract. The objective is to determine the prevalence of <em>C. glucuronolyticum</em> in genitourinary tract samples as well as their antimicrobial susceptibility profile.</div></div><div><h3>Methods</h3><div>A prospective study was conducted from 1st of November 2021 to the 30th of November 2022, for all genitourinary tract samples collected from male patients with suspicion of balanitis, prostatitis and urethritis. Antimicrobial susceptibility testing was performed in all <em>C. glucuronolyticum</em> isolates.</div></div><div><h3>Results</h3><div>A total of 73 <em>C. glucuronolyticum</em> isolates from 693 clinical specimens were obtained. This represents an overall <em>C. glucuronolyticum</em> prevalence of 10.5%. All strains were susceptible to vancomycin, linezolid and rifampicin, whereas 94%, 68% and 65% were resistant to clindamycin, tetracycline and ciprofloxacin, respectively.</div></div><div><h3>Conclusion</h3><div>Clinical microbiology laboratories should perform antimicrobial susceptibility testing against <em>C. glucuronolyticum</em> due to the significant rate of resistance to ciprofloxacin and tetracycline.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 3","pages":"Pages 162-164"},"PeriodicalIF":2.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24003331","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Corynebacterium glucuronolyticum (C. glucuronolyticum) is a species recently recognized as a potential pathogen of the male genitourinary tract. The objective is to determine the prevalence of C. glucuronolyticum in genitourinary tract samples as well as their antimicrobial susceptibility profile.

Methods

A prospective study was conducted from 1st of November 2021 to the 30th of November 2022, for all genitourinary tract samples collected from male patients with suspicion of balanitis, prostatitis and urethritis. Antimicrobial susceptibility testing was performed in all C. glucuronolyticum isolates.

Results

A total of 73 C. glucuronolyticum isolates from 693 clinical specimens were obtained. This represents an overall C. glucuronolyticum prevalence of 10.5%. All strains were susceptible to vancomycin, linezolid and rifampicin, whereas 94%, 68% and 65% were resistant to clindamycin, tetracycline and ciprofloxacin, respectively.

Conclusion

Clinical microbiology laboratories should perform antimicrobial susceptibility testing against C. glucuronolyticum due to the significant rate of resistance to ciprofloxacin and tetracycline.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Enfermedades infecciosas y microbiologia clinica 医学-传染病学

CiteScore

2.10

自引率

8.00%

发文量

194

审稿时长

29 days

期刊介绍： Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.